Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Research article

A pattern of unspecific somatic symptoms as long-term premonitory signs of type 2 diabetes: findings from the population-based MONICA/KORA cohort study, 1984-2009

Authors: Jens Baumert, Christa Meisinger, Karoline Lukaschek, Rebecca Thwing Emeny, Ina-Maria Rückert, Johannes Kruse, Karl-Heinz Ladwig

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Unspecific symptoms often proceed a serious chronic disease condition long before the onset of the disease. The role of an unspecific premonitory symptom (UPMS) pattern as premonitory signs of subsequent type 2 diabetes mellitus (T2DM) diagnosis independent of established cardio-metabolic risk factors is unclear and therefore was examined in the present study.

Methods

The study population consisted of 10,566 participants aged 25–74 years at baseline drawn from the population-based MONICA/KORA Cohort Study conducted in 1984-2009 in the Augsburg region (Germany). Unspecific premonitory symptoms were assessed following the Somatic Symptom Scale-8 (SSS-8). The impact of the score on T2DM risk within a mean follow-up time of 16 years was estimated by Cox regression.

Results

Within follow-up, 974 newly diagnosed T2DM cases were observed. The risk for T2DM increased by a hazard ratio (HR) of 1.03 (95% CI 1.01-1.04, p value < 0.001) for a one unit increase of the UPMS score in a Cox model adjusted for age, sex and survey. Additional adjustment for cardio-metabolic risk factors attenuated this effect (HR = 1.02) but significance remained (p value = 0.01).

Conclusions

Suffering from an elevated burden of unspecific somatic symptoms is associated with T2DM long before the onset and independent of established cardio-metabolic risk factors. Further research is needed to obtain insight in potential underlying pathophysiological mechanisms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Appels A, Mulder P: Excess fatigue as a precursor of myocardial infarction. Eur Heart J. 1988, 9: 758-764. 10.1093/eurheartj/9.7.758.CrossRefPubMed Appels A, Mulder P: Excess fatigue as a precursor of myocardial infarction. Eur Heart J. 1988, 9: 758-764. 10.1093/eurheartj/9.7.758.CrossRefPubMed
2.
go back to reference Graham MM, Westerhout CM, Kaul P, Norris CM, Armstrong PW: Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event. Am Heart J. 2008, 156: 1210-1216. 10.1016/j.ahj.2008.07.016. e1211CrossRefPubMed Graham MM, Westerhout CM, Kaul P, Norris CM, Armstrong PW: Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event. Am Heart J. 2008, 156: 1210-1216. 10.1016/j.ahj.2008.07.016. e1211CrossRefPubMed
3.
go back to reference Kroenke K, Price RK: Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993, 153: 2474-2480. 10.1001/archinte.1993.00410210102011.CrossRefPubMed Kroenke K, Price RK: Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993, 153: 2474-2480. 10.1001/archinte.1993.00410210102011.CrossRefPubMed
4.
go back to reference Barsky AJ: Assessing Somatic Symptoms in Clinical Practice. JAMA Intern Med. 2013, 174: 407-408.CrossRef Barsky AJ: Assessing Somatic Symptoms in Clinical Practice. JAMA Intern Med. 2013, 174: 407-408.CrossRef
5.
go back to reference Barsky AJ, Borus JF: Somatization and medicalization in the era of managed care. JAMA. 1995, 274: 1931-1934. 10.1001/jama.1995.03530240041038.CrossRefPubMed Barsky AJ, Borus JF: Somatization and medicalization in the era of managed care. JAMA. 1995, 274: 1931-1934. 10.1001/jama.1995.03530240041038.CrossRefPubMed
6.
go back to reference Khan AA, Khan A, Harezlak J, Tu W, Kroenke K: Somatic symptoms in primary care: etiology and outcome. Psychosomatics. 2003, 44: 471-478. 10.1176/appi.psy.44.6.471.CrossRefPubMed Khan AA, Khan A, Harezlak J, Tu W, Kroenke K: Somatic symptoms in primary care: etiology and outcome. Psychosomatics. 2003, 44: 471-478. 10.1176/appi.psy.44.6.471.CrossRefPubMed
8.
go back to reference Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992, 15: 815-819. 10.2337/diacare.15.7.815.CrossRefPubMed Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992, 15: 815-819. 10.2337/diacare.15.7.815.CrossRefPubMed
9.
go back to reference Sandbaek A, Griffin SJ, Rutten G, Davies M, Stolk R, Khunti K, Borch-Johnsen K, Wareham NJ, Lauritzen T: Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia. 2008, 51: 1127-1134. 10.1007/s00125-008-1013-0.CrossRefPubMedPubMedCentral Sandbaek A, Griffin SJ, Rutten G, Davies M, Stolk R, Khunti K, Borch-Johnsen K, Wareham NJ, Lauritzen T: Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia. 2008, 51: 1127-1134. 10.1007/s00125-008-1013-0.CrossRefPubMedPubMedCentral
10.
go back to reference Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care. 2002, 25: 1784-1789. 10.2337/diacare.25.10.1784.CrossRefPubMed Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care. 2002, 25: 1784-1789. 10.2337/diacare.25.10.1784.CrossRefPubMed
11.
go back to reference Association Diabetes Association: Screening for Type 2 Diabetes. Diabetes Care. 2000, 23 (Suppl 1): S20-S23. Association Diabetes Association: Screening for Type 2 Diabetes. Diabetes Care. 2000, 23 (Suppl 1): S20-S23.
12.
go back to reference Clark NG, Fox KM, Grandy S: Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Diabetes Care. 2007, 30: 2868-2873. 10.2337/dc07-0816.CrossRefPubMed Clark NG, Fox KM, Grandy S: Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Diabetes Care. 2007, 30: 2868-2873. 10.2337/dc07-0816.CrossRefPubMed
15.
go back to reference Lowel H, Doring A, Schneider A, Heier M, Thorand B, Meisinger C, Group MKS: The MONICA Augsburg surveys–basis for prospective cohort studies. Gesundheitswesen. 2005, 67 (Suppl 1): S13-18.CrossRefPubMed Lowel H, Doring A, Schneider A, Heier M, Thorand B, Meisinger C, Group MKS: The MONICA Augsburg surveys–basis for prospective cohort studies. Gesundheitswesen. 2005, 67 (Suppl 1): S13-18.CrossRefPubMed
16.
go back to reference WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988, 41: 105-114. 10.1016/0895-4356(88)90084-4.CrossRef WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988, 41: 105-114. 10.1016/0895-4356(88)90084-4.CrossRef
17.
go back to reference Holle R, Happich M, Lowel H, Wichmann HE, Group MKS: KORA–a research platform for population based health research. Gesundheitswesen. 2005, 67 (Suppl 1): S19-25.CrossRefPubMed Holle R, Happich M, Lowel H, Wichmann HE, Group MKS: KORA–a research platform for population based health research. Gesundheitswesen. 2005, 67 (Suppl 1): S19-25.CrossRefPubMed
18.
go back to reference WHO MONICA Project Principal Investigators: MONICA Psychosocial optional study. Suggested measurement instruments. 1989, Kopenhagen: Regional Office for Europe WHO MONICA Project Principal Investigators: MONICA Psychosocial optional study. Suggested measurement instruments. 1989, Kopenhagen: Regional Office for Europe
19.
go back to reference Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brahler E, Lowe B: The Somatic Symptom Scale-8 (SSS-8): A Brief Measure of Somatic Symptom Burden. JAMA Intern Med. 2014, 174: 399-407. 10.1001/jamainternmed.2013.12179.CrossRefPubMed Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brahler E, Lowe B: The Somatic Symptom Scale-8 (SSS-8): A Brief Measure of Somatic Symptom Burden. JAMA Intern Med. 2014, 174: 399-407. 10.1001/jamainternmed.2013.12179.CrossRefPubMed
20.
go back to reference Kroenke K, Spitzer RL, Williams JB: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002, 64: 258-266. 10.1097/00006842-200203000-00008.CrossRefPubMed Kroenke K, Spitzer RL, Williams JB: The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002, 64: 258-266. 10.1097/00006842-200203000-00008.CrossRefPubMed
21.
go back to reference Zerssen D v: Die Beschwerden-Liste. Klinische Selbstbeurteilungsfragebögen aus dem Münchner Psychiatrischen Informationssystem. Psychis - Manuale, Allgemeiner Teil. 1976, Weinheim: Beltz Zerssen D v: Die Beschwerden-Liste. Klinische Selbstbeurteilungsfragebögen aus dem Münchner Psychiatrischen Informationssystem. Psychis - Manuale, Allgemeiner Teil. 1976, Weinheim: Beltz
22.
go back to reference Meisinger C, Heier M, Loewel H: Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia. 2005, 48: 235-241.CrossRefPubMed Meisinger C, Heier M, Loewel H: Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia. 2005, 48: 235-241.CrossRefPubMed
23.
go back to reference Keil U, Liese AD, Hense HW, Filipiak B, Doring A, Stieber J, Lowel H: Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J. 1998, 19: 1197-1207. 10.1053/euhj.1998.1089.CrossRefPubMed Keil U, Liese AD, Hense HW, Filipiak B, Doring A, Stieber J, Lowel H: Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J. 1998, 19: 1197-1207. 10.1053/euhj.1998.1089.CrossRefPubMed
24.
go back to reference Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002, 162: 82-89. 10.1001/archinte.162.1.82.CrossRefPubMed Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002, 162: 82-89. 10.1001/archinte.162.1.82.CrossRefPubMed
25.
go back to reference Ladwig KH, Marten-Mittag B, Baumert J, Lowel H, Doring A, Investigators K: Case-finding for depressive and exhausted mood in the general population: reliability and validity of a symptom-driven diagnostic scale. Results from the prospective MONICA/KORA Augsburg Study. Ann Epidemiol. 2004, 14: 332-338. 10.1016/j.annepidem.2003.09.003.CrossRefPubMed Ladwig KH, Marten-Mittag B, Baumert J, Lowel H, Doring A, Investigators K: Case-finding for depressive and exhausted mood in the general population: reliability and validity of a symptom-driven diagnostic scale. Results from the prospective MONICA/KORA Augsburg Study. Ann Epidemiol. 2004, 14: 332-338. 10.1016/j.annepidem.2003.09.003.CrossRefPubMed
26.
go back to reference Royston P, Sauerbrei W: Building multivariable regression models with continuous covariates in clinical epidemiology–with an emphasis on fractional polynomials. Methods Inf Med. 2005, 44: 561-571.PubMed Royston P, Sauerbrei W: Building multivariable regression models with continuous covariates in clinical epidemiology–with an emphasis on fractional polynomials. Methods Inf Med. 2005, 44: 561-571.PubMed
27.
go back to reference Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172. 10.1002/sim.2929. discussion 207-112CrossRefPubMed Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172. 10.1002/sim.2929. discussion 207-112CrossRefPubMed
28.
go back to reference Mühlenbruch K: Ein Makro zur Berechnung von Diskriminanz- und Reklassifizierungsstatistiken für die Verbesserung eines Prädiktionsmodells bei Anwendung der Cox-Regression. Proceedings der 16 Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE): 8-9 March 2012; Dresden. Edited by: Hilbert A, Minkenberg R. 2012, Aachen: Shaker, 249-262. Mühlenbruch K: Ein Makro zur Berechnung von Diskriminanz- und Reklassifizierungsstatistiken für die Verbesserung eines Prädiktionsmodells bei Anwendung der Cox-Regression. Proceedings der 16 Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE): 8-9 March 2012; Dresden. Edited by: Hilbert A, Minkenberg R. 2012, Aachen: Shaker, 249-262.
29.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61: 344-349. 10.1016/j.jclinepi.2007.11.008.CrossRefPubMed von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61: 344-349. 10.1016/j.jclinepi.2007.11.008.CrossRefPubMed
30.
go back to reference Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. JAMA. 2003, 290: 2945-2951. 10.1001/jama.290.22.2945.CrossRefPubMed Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. JAMA. 2003, 290: 2945-2951. 10.1001/jama.290.22.2945.CrossRefPubMed
31.
go back to reference Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM: The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2011, 25: 73-79. 10.1038/jhh.2010.91.CrossRefPubMed Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM: The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2011, 25: 73-79. 10.1038/jhh.2010.91.CrossRefPubMed
32.
go back to reference Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension. 2011, 57: 132-140. 10.1161/HYPERTENSIONAHA.110.163576.CrossRefPubMed Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension. 2011, 57: 132-140. 10.1161/HYPERTENSIONAHA.110.163576.CrossRefPubMed
33.
go back to reference Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005, 183: 308-315. 10.1016/j.atherosclerosis.2005.03.010.CrossRefPubMed Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005, 183: 308-315. 10.1016/j.atherosclerosis.2005.03.010.CrossRefPubMed
34.
go back to reference Emeny R, Lacruz ME, Baumert J, Zierer A, von Eisenhart RA, Autenrieth C, Herder C, Koenig W, Thorand B, Ladwig KH: Job strain associated CRP is mediated by leisure time physical activity: results from the MONICA/KORA study. Brain Behav Immun. 2012, 26: 1077-1084. 10.1016/j.bbi.2012.07.004.CrossRefPubMed Emeny R, Lacruz ME, Baumert J, Zierer A, von Eisenhart RA, Autenrieth C, Herder C, Koenig W, Thorand B, Ladwig KH: Job strain associated CRP is mediated by leisure time physical activity: results from the MONICA/KORA study. Brain Behav Immun. 2012, 26: 1077-1084. 10.1016/j.bbi.2012.07.004.CrossRefPubMed
35.
go back to reference Bergstrom G, Behre CJ, Schmidt C: Moderate intensities of leisure-time physical activity are associated with lower levels of high-sensitivity C-reactive protein in healthy middle-aged men. Angiology. 2012, 63: 412-415. 10.1177/0003319711423386.CrossRefPubMed Bergstrom G, Behre CJ, Schmidt C: Moderate intensities of leisure-time physical activity are associated with lower levels of high-sensitivity C-reactive protein in healthy middle-aged men. Angiology. 2012, 63: 412-415. 10.1177/0003319711423386.CrossRefPubMed
36.
go back to reference Lasselin J, Laye S, Dexpert S, Aubert A, Gonzalez C, Gin H, Capuron L: Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav Immun. 2012, 26: 1211-1219. 10.1016/j.bbi.2012.03.003.CrossRefPubMed Lasselin J, Laye S, Dexpert S, Aubert A, Gonzalez C, Gin H, Capuron L: Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav Immun. 2012, 26: 1211-1219. 10.1016/j.bbi.2012.03.003.CrossRefPubMed
37.
go back to reference Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW: Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology. 2013, 38: 1573-1585. 10.1016/j.psyneuen.2013.01.002.CrossRefPubMed Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW: Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology. 2013, 38: 1573-1585. 10.1016/j.psyneuen.2013.01.002.CrossRefPubMed
38.
go back to reference Lieb R, Meinlschmidt G, Araya R: Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med. 2007, 69: 860-863. 10.1097/PSY.0b013e31815b0103.CrossRefPubMed Lieb R, Meinlschmidt G, Araya R: Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med. 2007, 69: 860-863. 10.1097/PSY.0b013e31815b0103.CrossRefPubMed
39.
go back to reference Ladwig KH, Marten-Mittag B, Lacruz ME, Henningsen P, Creed F: Screening for multiple somatic complaints in a population-based survey: does excessive symptom reporting capture the concept of somatic symptom disorders? Findings from the MONICA-KORA Cohort Study. J Psychosom Res. 2010, 68: 427-437. 10.1016/j.jpsychores.2010.01.009.CrossRefPubMed Ladwig KH, Marten-Mittag B, Lacruz ME, Henningsen P, Creed F: Screening for multiple somatic complaints in a population-based survey: does excessive symptom reporting capture the concept of somatic symptom disorders? Findings from the MONICA-KORA Cohort Study. J Psychosom Res. 2010, 68: 427-437. 10.1016/j.jpsychores.2010.01.009.CrossRefPubMed
40.
go back to reference Creed F, Barsky A: A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res. 2004, 56: 391-408. 10.1016/S0022-3999(03)00622-6.CrossRefPubMed Creed F, Barsky A: A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res. 2004, 56: 391-408. 10.1016/S0022-3999(03)00622-6.CrossRefPubMed
41.
go back to reference Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation. 2004, 109: II2-10. 10.1161/01.CIR.0000122867.89751.59.CrossRefPubMed Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation. 2004, 109: II2-10. 10.1161/01.CIR.0000122867.89751.59.CrossRefPubMed
42.
go back to reference Hansel A, Hong S, Camara RJ, von Kanel R: Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci Biobehav Rev. 2010, 35: 115-121. 10.1016/j.neubiorev.2009.12.012.CrossRefPubMed Hansel A, Hong S, Camara RJ, von Kanel R: Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci Biobehav Rev. 2010, 35: 115-121. 10.1016/j.neubiorev.2009.12.012.CrossRefPubMed
43.
go back to reference Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996, 19: 1097-1102. 10.2337/diacare.19.10.1097.CrossRefPubMed Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996, 19: 1097-1102. 10.2337/diacare.19.10.1097.CrossRefPubMed
44.
go back to reference Engum A: The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007, 62: 31-38. 10.1016/j.jpsychores.2006.07.009.CrossRefPubMed Engum A: The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007, 62: 31-38. 10.1016/j.jpsychores.2006.07.009.CrossRefPubMed
45.
go back to reference Lukaschek K, Baumert J, Kruse J, Emeny RT, Lacruz ME, Huth C, Thorand B, Holle R, Rathmann W, Meisinger C, Ladwig KH: Relationship between posttraumatic stress disorder and type 2 diabetes in a population-based cross-sectional study with 2970 participants. J Psychosom Res. 2013, 74: 340-345. 10.1016/j.jpsychores.2012.12.011.CrossRefPubMed Lukaschek K, Baumert J, Kruse J, Emeny RT, Lacruz ME, Huth C, Thorand B, Holle R, Rathmann W, Meisinger C, Ladwig KH: Relationship between posttraumatic stress disorder and type 2 diabetes in a population-based cross-sectional study with 2970 participants. J Psychosom Res. 2013, 74: 340-345. 10.1016/j.jpsychores.2012.12.011.CrossRefPubMed
46.
go back to reference Chen PC, Chan YT, Chen HF, Ko MC, Li CY: Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013, 36: 376-382. 10.2337/dc12-0473.CrossRefPubMedPubMedCentral Chen PC, Chan YT, Chen HF, Ko MC, Li CY: Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013, 36: 376-382. 10.2337/dc12-0473.CrossRefPubMedPubMedCentral
47.
go back to reference Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008, 31: 2383-2390. 10.2337/dc08-0985.CrossRefPubMedPubMedCentral Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008, 31: 2383-2390. 10.2337/dc08-0985.CrossRefPubMedPubMedCentral
48.
go back to reference Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, Ismail K: A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013, 36: 480-489. 10.2337/dc12-1442.CrossRefPubMedPubMedCentral Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, Ismail K: A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013, 36: 480-489. 10.2337/dc12-1442.CrossRefPubMedPubMedCentral
49.
go back to reference Kengne AP, Beulens JW, Peelen LM, Moons KG, van der Schouw YT, Schulze MB, Spijkerman AM, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li K, Mühlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D: Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol. 2014, 2: 19-29. 10.1016/S2213-8587(13)70103-7.CrossRefPubMed Kengne AP, Beulens JW, Peelen LM, Moons KG, van der Schouw YT, Schulze MB, Spijkerman AM, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li K, Mühlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D: Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol. 2014, 2: 19-29. 10.1016/S2213-8587(13)70103-7.CrossRefPubMed
Metadata
Title
A pattern of unspecific somatic symptoms as long-term premonitory signs of type 2 diabetes: findings from the population-based MONICA/KORA cohort study, 1984-2009
Authors
Jens Baumert
Christa Meisinger
Karoline Lukaschek
Rebecca Thwing Emeny
Ina-Maria Rückert
Johannes Kruse
Karl-Heinz Ladwig
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-87

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.